Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celia A Schiffer

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
AIDS Reviews|September 30, 2008
Resilience to resistance of HIV-1 protease inhibitors: profile of darunavirEric Lefebvre, Celia A Schiffer
Journal of Chemical Theory and Computation|June 15, 2010
Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRVYufeng Cai, Celia A Schiffer
Acta Crystallographica. Section D, Biological Crystallography|May 7, 2015
REdiii: a pipeline for automated structure solutionMarkus Frederik Bohn, Celia A Schiffer
Protein Science : a Publication of the Protein Society|June 27, 2019
APOBEC3s: DNA-editing human cytidine deaminasesTania V Silvas, Celia A Schiffer
ACS Infectious Diseases|March 9, 2022
Call for Papers: Drug Resistance in Infectious Diseases and BeyondCelia A Schiffer, Daria J Hazuda
Chemical Reviews|March 24, 2021
Introduction: Drug ResistanceNese Kurt Yilmaz, Celia A Schiffer
Proteins|June 3, 2006
Substrate specificity in HIV-1 protease by a biased sequence search methodNevra Ozer, Turkan Haliloglu, Celia A Schiffer
Biophysical Journal|September 7, 2010
Rationale for more diverse inhibitors in competition with substrates in HIV-1 proteaseNevra Ozer, Celia A Schiffer, Turkan Haliloglu
Biophysical Journal|July 30, 2003
Structure-based prediction of potential binding and nonbinding peptides to HIV-1 proteaseNese Kurt, Turkan Haliloglu, Celia A Schiffer
Current Opinion in HIV and AIDS|April 18, 2009
New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitorsMadhavi N L Nalam, Celia A Schiffer
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
AIDS Reviews|September 30, 2008
Resilience to resistance of HIV-1 protease inhibitors: profile of darunavirEric Lefebvre, Celia A Schiffer
Journal of Chemical Theory and Computation|June 15, 2010
Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRVYufeng Cai, Celia A Schiffer
Acta Crystallographica. Section D, Biological Crystallography|May 7, 2015
REdiii: a pipeline for automated structure solutionMarkus Frederik Bohn, Celia A Schiffer
Protein Science : a Publication of the Protein Society|June 27, 2019
APOBEC3s: DNA-editing human cytidine deaminasesTania V Silvas, Celia A Schiffer
ACS Infectious Diseases|March 9, 2022
Call for Papers: Drug Resistance in Infectious Diseases and BeyondCelia A Schiffer, Daria J Hazuda
Chemical Reviews|March 24, 2021
Introduction: Drug ResistanceNese Kurt Yilmaz, Celia A Schiffer
Proteins|June 3, 2006
Substrate specificity in HIV-1 protease by a biased sequence search methodNevra Ozer, Turkan Haliloglu, Celia A Schiffer
Biophysical Journal|September 7, 2010
Rationale for more diverse inhibitors in competition with substrates in HIV-1 proteaseNevra Ozer, Celia A Schiffer, Turkan Haliloglu
Biophysical Journal|July 30, 2003
Structure-based prediction of potential binding and nonbinding peptides to HIV-1 proteaseNese Kurt, Turkan Haliloglu, Celia A Schiffer
Current Opinion in HIV and AIDS|April 18, 2009
New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitorsMadhavi N L Nalam, Celia A Schiffer
Pageof 21